References
- Javery O, Krajewski K, O’Regan K, Kis B, Giardino A, Jagannathan J et al. A to Z of extraskeletal Ewing sarcoma family of tumors in adults: imaging features of primary disease, metastatic patterns, and treatment responses. AJR Am J Roentgenol. 2011;197:W1015-22.
- Enrique de Alava, Gerald WL. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 2000; 18:204-13.
- Pandey, R., Batra, R., Dhaigude, P. et al. Primitive neuroectodermal tumor of the kidney: a rare case. Afr J Urol 2021; 27:45.
- Ekram T, Elsayes KM, Cohan RH, Francis IR. Computed tomography and magnetic resonance features of renal Ewing sarcoma. Acta Radiol. 2008; 49:1085-90.
- Li J, Nie F, Li Y. Extraosseous Ewing’s sarcoma/peripheral primitive neuroectodermal tumour of the kidney: a case report and literature review. BMC Urol. 2022; 22:197.
- Zhang S, Li Y, Wang R, Song B. Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a case report and literature review. Transl Androl Urol. 2019; 8:562-566.
- Angel JR, Alfred A, Sakhuja A, Sells RE, Zechlinski JJ. Ewing’s sarcoma of the kidney. Int J Clin Oncol. 2010; 15:314-8.
- Risi E, Iacovelli R, Altavilla A, Alesini D, Palazzo A, Mosillo C et al. Clinical and pathological features of primary neuroectodermal tumor/Ewing sarcoma of the kidney. Urology. 2013; 82:382-6.
- Thyavihally YB, Tongaonkar HB, Gupta S, Kurkure PA, Amare P, Muckaden MA et al. Primitive neuroectodermal tumor of the kidney: a single institute series of 16 patients. Urology. 2008; 71:292-6.
- Liang L, Song H, Ma B, Zhang Z, Zhu K, Li Q, et al. Renal Ewing’s sarcoma/primitive neuroectodermal tumor (PNET): a case series of 7 patients and literature review. Transl Androl Urol. 2021; 10 :548-554.
- Sadiq M, Ahmad I, Shuja J, Ahmad K. Primary Ewing sarcoma of the kidney: a case report and treatment review. CEN Case Rep. 2017; 6:132-135.
- Niederhuber JE, Armitage JO et al. Abeloff’s Clinical Oncology. 6th Edition. Elsevier. 2020; 90: 1655-1692.
- Nazemi A, Daneshmand S. Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival. Urol Oncol. 2020;38:334-343.
- Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-4.
- Rowe RG, Thomas DG, Schuetze SM, Hafez KS, Lawlor ER, Chugh R. Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal tumors. Urology. 2013; 81:347-53.
- Chen H., Li, Y., Zeng, Q., & Wu, G. Renal primitive neuroectodermal tumor: A rare case with a good prognosis. Front. Surg. 2023.
- Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies. Urology. 2006; 68:257-62.
- Parada D, Godoy A, Liuzzi F, Pelia KB, Romero A, Parada AM. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney. An infrequent finding. Arch Esp Urol. 2007; 60:321-5.
- Patra S, Trivedi P. Primary Ewing sarcoma of the kidney: A series of four cases. Malays J Pathol. 2022; 44:93-99.
- Ellison, D. A., Parham, D. M., Bridge, J., & Beckwith, J. B. Immunohistochemistry of primary malignant neuroepithelial tumors of the kidney: A potential source of confusion?: A study of 30 cases from the National Wilms Tumor Study Pathology Center. Human Pathology. 2007; 38: 205-211.
- Mangray S, Kelly DR, LeGuellec S, Fridman E, Aggarwal S, Shago M et al. Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis. Am J Surg Pathol. 2018; 42:1360-1369.
- Italiano A, Sung YS, Zhang L, Singer S, Maki RG, Coindre JM et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012; 51: 207:18.
- WHO Classification of Tumors Editorial Board. Soft Tissue and Bone Tumours 5th Edition. 2020; 2:321-333.
- Yang J, Xu Y, Chen Y, Li T, Zhang X, Hu T et al. Therapeutic perspectives for adult soft tissue sarcoma-updates from the 2022 ASCO annual meeting. Cancer Biol Med. 2022; 19:1496–502.
- Sanfilippo R. Trabectedin in advanced retroperitoneal well differentiated/dedifferentiated liposarcoma and leiomyosarcoma (TRAVELL): results of a phase 2 study from Italian sarcoma group (ISG). J Clin Oncol. 2022; 40: 11575
- Van Tine BA. A phase 1b study of unesbulin (PTC596) plus dacarbazine for the treatment of patients with locally recurrent, unresectable, or metastatic relapsed/refractory leiomyosarcoma. J Clin Oncol. 2022; 40: 11507.
- Liu X, Xu J, Li F, Liao Z, Ren Z, Zhu L, et al. Efficacy and safety of the VEGFR2 inhibitor Apatinib for metastatic soft tissue sarcoma: Chinese Cohort Data from NCT03121846. Biomed Pharmacother. 2020; 122: 109587
- Chen TW-W. A phase Ib/II study of the combination of lenvatinib (L) and eribulin (E) in advanced liposarcoma (LPS) and leiomyosarcoma (LMS) (LEADER): efficacy updates. J Clin Oncol. 2022; 40: 11506.